SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-052913
Filing Date
2019-02-27
Accepted
2019-02-27 08:08:30
Documents
5
Period of Report
2019-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d712610d8k.htm 8-K 19832
2 EX-1.1 d712610dex11.htm EX-1.1 178551
3 EX-5.1 d712610dex51.htm EX-5.1 5999
4 EX-99.1 d712610dex991.htm EX-99.1 7706
5 EX-99.2 d712610dex992.htm EX-99.2 7929
  Complete submission text file 0001193125-19-052913.txt   221130
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 19635860
SIC: 2834 Pharmaceutical Preparations